Given that certain cancer drugs such as doxorubicin (Dox) also generate oxidant stress and may synergize with TRAIL via ROS, we further sought to determine whether the mechanisms of TRAIL sensitization in cancer cells by PL and Dox converge on ROS production. Here, TNFSF10 is linked to cancer.